NL193583C - Ethyleendiaminemonoamidederivaten, werkwijzen ter bereiding daarvan, alsmede farmaceutische preparaten en de toepassing daarvan. - Google Patents

Ethyleendiaminemonoamidederivaten, werkwijzen ter bereiding daarvan, alsmede farmaceutische preparaten en de toepassing daarvan. Download PDF

Info

Publication number
NL193583C
NL193583C NL8502374A NL8502374A NL193583C NL 193583 C NL193583 C NL 193583C NL 8502374 A NL8502374 A NL 8502374A NL 8502374 A NL8502374 A NL 8502374A NL 193583 C NL193583 C NL 193583C
Authority
NL
Netherlands
Prior art keywords
aminoethyl
carboxamide
tert
hydrogen
butyl
Prior art date
Application number
NL8502374A
Other languages
English (en)
Dutch (nl)
Other versions
NL193583B (nl
NL8502374A (nl
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH4132/84A external-priority patent/CH661043A5/de
Priority claimed from CH2404/85A external-priority patent/CH664755A5/de
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NL8502374A publication Critical patent/NL8502374A/nl
Publication of NL193583B publication Critical patent/NL193583B/xx
Application granted granted Critical
Publication of NL193583C publication Critical patent/NL193583C/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
  • Pyrrole Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NL8502374A 1984-08-29 1985-08-29 Ethyleendiaminemonoamidederivaten, werkwijzen ter bereiding daarvan, alsmede farmaceutische preparaten en de toepassing daarvan. NL193583C (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH413284 1984-08-29
CH4132/84A CH661043A5 (en) 1984-08-29 1984-08-29 Ethylenediamine monoamide derivatives
CH240485 1985-06-05
CH2404/85A CH664755A5 (de) 1985-06-05 1985-06-05 Aethylendiaminmonoamid-derivat.

Publications (3)

Publication Number Publication Date
NL8502374A NL8502374A (nl) 1986-03-17
NL193583B NL193583B (nl) 1999-11-01
NL193583C true NL193583C (nl) 2000-03-02

Family

ID=25690366

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8502374A NL193583C (nl) 1984-08-29 1985-08-29 Ethyleendiaminemonoamidederivaten, werkwijzen ter bereiding daarvan, alsmede farmaceutische preparaten en de toepassing daarvan.

Country Status (28)

Country Link
US (1) US4764522A (mo)
JP (2) JPH0764817B2 (mo)
KR (1) KR920007269B1 (mo)
AR (1) AR244209A1 (mo)
AT (1) AT391694B (mo)
AU (1) AU582381B2 (mo)
BE (1) BE903110A (mo)
BG (1) BG60401B1 (mo)
CA (1) CA1261335A (mo)
DE (1) DE3530046C2 (mo)
DK (1) DK162888C (mo)
ES (2) ES8705372A1 (mo)
FI (1) FI83511C (mo)
FR (1) FR2569694B1 (mo)
GB (1) GB2163746B (mo)
GR (1) GR852071B (mo)
HU (1) HU197309B (mo)
IE (1) IE58788B1 (mo)
IL (1) IL76176A (mo)
IT (1) IT1190385B (mo)
LU (1) LU86049A1 (mo)
MC (1) MC1696A1 (mo)
NL (1) NL193583C (mo)
NO (1) NO169711C (mo)
NZ (1) NZ213193A (mo)
PH (1) PH22813A (mo)
PT (1) PT81041B (mo)
SE (1) SE464083B (mo)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5204482A (en) * 1988-07-28 1993-04-20 Hoffman-Laroche Inc. Compounds for treating and preventing cognitive diseases and depression and methods of making same
EP0352581A3 (de) * 1988-07-28 1990-07-04 F. Hoffmann-La Roche Ag Aethylendiaminmonoamid-Derivate
CA2008878C (en) * 1989-02-28 2003-01-21 Michelangelo Scalone Process for preparing pyridine-2-carboxamides
EP0451790A1 (de) * 1990-04-12 1991-10-16 Hoechst Aktiengesellschaft 3,5-disubstituierte 2-Isoxazoline und Isoxazole, Verfahren zu deren Herstellung, diese enthaltende Mittel und ihre Verwendung
JPH04295470A (ja) * 1991-03-22 1992-10-20 Wakamoto Pharmaceut Co Ltd モノアミンオキシダーゼ−ｂ酵素阻害活性を有する１，２，４−オキサジアゾール誘導体及びその製造法
US5545658A (en) * 1991-03-26 1996-08-13 Hoffman-La Roche Inc. Amino acid derivatives
RU2097378C1 (ru) * 1991-03-26 1997-11-27 Ф.Хоффманн-Ля Рош Аг ПРОИЗВОДНЫЕ N-АЦИЛ- α -АМИНОКИСЛОТЫ ИЛИ ИХ ФИЗИОЛОГИЧЕСКИ ПРИЕМЛЕМЫЕ СОЛИ, ПРОСТЫЕ ИЛИ СЛОЖНЫЕ ЭФИРЫ, АМИДЫ ИЛИ ГИДРАТЫ И КОМПОЗИЦИЯ ИНГИБИРУЮЩАЯ СВЯЗЫВАНИЕ АДГЕЗИВНЫХ ПРОТЕИНОВ С ТРОМБОЦИТАМИ И АГРЕГАЦИЮ ТРОМБОЦИТОВ
FR2803592A1 (fr) * 2000-01-06 2001-07-13 Aventis Cropscience Sa Nouveaux derives de l'acide 3-hydroxypicolinique, leur procede de preparation et compositions fongicides les contenant.
CN102526045A (zh) * 2001-12-06 2012-07-04 法布罗根股份有限公司 提高内源性红细胞生成素(epo)的方法
US6667327B2 (en) * 2002-02-04 2003-12-23 Hoffmann-La Roche Inc. Pyridine amido derivatives
ATE411027T1 (de) * 2003-10-23 2008-10-15 Hoffmann La Roche Benzazepin-derivate als mao-b-hemmer
US8138209B2 (en) * 2005-07-13 2012-03-20 Jenrin Discovery, Inc. Substituted picolinamides as MAO-B inhibitors useful for treating obesity
WO2008010794A1 (en) * 2006-07-18 2008-01-24 Renaissance Medicine, Llc Pharmaceutical preparations of crystalline lazabemide
WO2008010796A1 (en) * 2006-07-18 2008-01-24 Renaissance Medicine, Llc Process for preparing pyridine-2-carboxamides and intermediates therefor
FR2904317A1 (fr) * 2006-07-27 2008-02-01 Inst Nat Sante Rech Med Analogues d'halogenobenzamides marques a titre de radiopharmaceutiques
EP2085390A1 (en) 2008-01-31 2009-08-05 Institut National De La Sante Et De La Recherche Medicale (Inserm) Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors
WO2011028740A1 (en) * 2009-09-03 2011-03-10 Glaxo Group Limited ENaC BLOCKERS
SMT202400092T1 (it) 2013-06-13 2024-05-14 Akebia Therapeutics Inc Composizioni e metodi per il trattamento dell'anemia
PL3277270T3 (pl) 2015-04-01 2022-02-14 Akebia Therapeutics, Inc. Kompozycje i sposoby leczenia niedokrwistości
WO2019028150A1 (en) 2017-08-01 2019-02-07 Akebia Therapeutics, Inc. COMPOSITIONS FOR USE IN METHODS OF TREATING HEMOGLOBINOPATHIES

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB451304A (en) * 1934-07-07 1936-08-04 Karl Merck Process for the manufacture of new derivatives of pyrazinemonocarboxylic acid
DE1217385B (de) * 1962-11-09 1966-05-26 J. R. Geigy A.-G., Basel (Schweiz) Verfahren zur Herstellung von neuen Picolinsäurederivafen
NL6707566A (mo) * 1966-08-17 1968-02-19
GB1509527A (en) * 1974-06-05 1978-05-04 Ici Ltd 1-(aryl-or heteroaryl)oxy-3-(substituted-amino)propan-2-ol derivatives processes for their manufacture and pharmaceutical compositions containing them
US4041032A (en) * 1974-01-16 1977-08-09 Yamanouchi Pharmaceutical Co., Ltd. Pyrazine derivatives
GB1509300A (en) * 1975-12-05 1978-05-04 Ici Ltd Ethanolamine derivatives
DE3239573A1 (de) * 1981-10-28 1983-05-19 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Substituierte picolinsaeuren, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende arzneimittel
IE54220B1 (en) * 1981-12-23 1989-07-19 Ici Plc Phenol esters
CH653670A5 (de) * 1983-03-03 1986-01-15 Hoffmann La Roche Benzamid-derivate.

Also Published As

Publication number Publication date
LU86049A1 (de) 1986-09-11
JPH0825879B2 (ja) 1996-03-13
US4764522A (en) 1988-08-16
KR920007269B1 (ko) 1992-08-29
DK162888C (da) 1992-05-11
MC1696A1 (fr) 1986-07-18
JPH07300417A (ja) 1995-11-14
IT1190385B (it) 1988-02-16
FI83511B (fi) 1991-04-15
ATA251585A (de) 1990-05-15
BE903110A (fr) 1986-02-24
DE3530046C2 (de) 1997-12-04
GB2163746A (en) 1986-03-05
IE58788B1 (en) 1993-11-17
NO169711C (no) 1992-07-29
DK162888B (da) 1991-12-23
SE8504014L (sv) 1986-03-01
AT391694B (de) 1990-11-12
AU582381B2 (en) 1989-03-23
PT81041B (pt) 1988-01-22
SE8504014D0 (sv) 1985-08-28
AR244209A1 (es) 1993-10-29
PH22813A (en) 1988-12-27
BG96645A (bg) 1993-12-24
FR2569694A1 (fr) 1986-03-07
FI83511C (fi) 1991-07-25
IL76176A (en) 1989-02-28
IE852118L (en) 1986-02-28
FR2569694B1 (fr) 1991-05-03
ES552399A0 (es) 1987-11-01
NO169711B (no) 1992-04-21
FI853140L (fi) 1986-03-01
CA1261335A (en) 1989-09-26
GB2163746B (en) 1988-06-22
FI853140A0 (fi) 1985-08-15
JPS6160657A (ja) 1986-03-28
DK391485A (da) 1986-03-01
KR870002078A (ko) 1987-03-30
HU197309B (en) 1989-03-28
GB8521358D0 (en) 1985-10-02
ES546482A0 (es) 1987-05-01
ES8705372A1 (es) 1987-05-01
IT8521865A0 (it) 1985-08-05
NL193583B (nl) 1999-11-01
GR852071B (mo) 1985-12-24
DE3530046A1 (de) 1986-03-13
PT81041A (en) 1985-09-01
NO853390L (no) 1986-03-03
NL8502374A (nl) 1986-03-17
BG60401B1 (en) 1995-02-28
AU4663685A (en) 1986-03-06
NZ213193A (en) 1989-10-27
JPH0764817B2 (ja) 1995-07-12
DK391485D0 (da) 1985-08-28
SE464083B (sv) 1991-03-04
HUT38317A (en) 1986-05-28
IL76176A0 (en) 1985-12-31
ES8800158A1 (es) 1987-11-01

Similar Documents

Publication Publication Date Title
CA2471059C (en) Pyrimidine a2b selective antagonist compounds, their synthesis and use
US6245916B1 (en) Aminotriazole compounds
US4886803A (en) Benzimidazole derivatives
KR100231089B1 (ko) 혈소판 응집 억제제인 헤테로시클릭 유도체
DE69411317T2 (de) Indoloylguanidinderivate als Inhibitoren des Natrium-Protonen Austauschs
NL8502374A (nl) Ethyleendiaminemonoamidederivaten, werkwijzen ter bereiding daarvan, alsmede farmaceutische preparaten en de toepassing daarvan.
SK12042003A3 (sk) Deriváty N-(arylsulfonyl)-beta-aminokyseliny obsahujúce aminometylovú skupinu, spôsob ich prípravy, farmaceutické kompozície, ktoré ich obsahujú, a ich použitie
CA2195850A1 (en) Substituted indoles
WO1998007718A1 (en) Non-peptide bombesin receptor antagonists
EP0352581A2 (de) Aethylendiaminmonoamid-Derivate
KR940009528B1 (ko) 헤테로 고리 화합물의 제조 방법
EP0769007A1 (en) 2-ureido-benzamide derivatives
CA2525442A1 (en) Cyanofluoropyrrolidine derivatives
US5565579A (en) (1H-indol-1-yl)-2-(amino)acetamides and related (1H-indol-1-yl)-(aminoalkyl)amides
CA2530310C (en) Substituted diketopiperazines and their use as oxytocin antagonists
JP2003231633A (ja) 医薬組成物
JP2000344748A (ja) ３−芳香族置換プロピオン酸またはアクリル酸化合物
DE68917049T2 (de) Furylthiazol-Derivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten.
JP2009514817A (ja) 新規インドール含有ベータ−アゴニスト、それらの製造方法及び薬物としてのそれらの使用
HU193556B (en) Process for preparing benzamide derivatives
WO1997003059A1 (en) 4-(substituted aminomethyl)thiazoline derivatives
WO1996028416A1 (en) Aminophenol derivatives
CZ340599A3 (cs) Derivát kyseliny chinolin-2-karboxylové
KR20010076973A (ko) 피롤 골격을 가진 선택적 ＦＸａ 억제제

Legal Events

Date Code Title Description
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: HOFFMANN-LA ROCHE AG. F. -

BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V4 Discontinued because of reaching the maximum lifetime of a patent

Effective date: 20050829